Patent details

EP2870246 Title: OLIGONUCLEOTIDE FOR THE TREATMENT OF MUSCULAR DYSTROPHY PATIENTS

Basic Information

Publication number:
EP2870246
PCT Application Number:
NL2013050487
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137398475
PCT Publication Number:
WO2014007620
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OLIGONUCLEOTIDE FOR THE TREATMENT OF MUSCULAR DYSTROPHY PATIENTS
French Title of Invention:
OLIGONUCLÉOTIDE POUR LE TRAITEMENT DE PATIENTS ATTEINTS DE DYSTROPHIE MUSCULAIRE
German Title of Invention:
OLIGONUKLEOTID ZUR BEHANDLUNG VON PATIENTEN MIT MUSKULÄRER DYSTROPHIE
SPC Number:

Dates

Filing date:
03/07/2013
Grant date:
11/09/2019
EP Publication Date:
13/05/2015
PCT Publication Date:
09/01/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2019
EP B1 Publication Date:
11/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/07/2020
Expiration date:
03/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/09/2019
 
 

Name:
BioMarin Technologies B.V.
Address:
J.H. Oortweg 21, 2333 CH Leiden, Netherlands (NL)

Inventor

Name:
VAN DEUTEKOM, Judith Christina Theodora
Address:
Netherlands (NL)

Priority

1

Priority Number:
201261667517 P
Priority Date:
03/07/2012
Priority Country:
United States (US)

2

Priority Number:
12174781
Priority Date:
03/07/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/7088; C12N 15/113;

Publication

European Patent Bulletin

Issue number:
201937
Publication date:
11/09/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages